Storia della carriera di Li Deng-Ke
Precedenti posizioni note di Li Deng-Ke
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RICH PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 29/04/2011 | 29/03/2013 |
| Direttore/Membro del Consiglio | 29/04/2011 | 29/03/2013 | |
| Direttore Finanziario/CFO | 29/04/2011 | 29/03/2013 | |
| Presidente | 29/04/2011 | 29/03/2013 | |
| KTV Ltd. | Corporate Officer/Principal | - | - |
Formazione di Li Deng-Ke
| Sichuan Normal University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Cina | 3 |
| Stati Uniti | 2 |
Posizioni
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
| Director of Finance/CFO | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
| KTV Ltd. |
- Borsa valori
- Insiders
- Li Deng-Ke
- Esperienza
